We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AREN icon
11201
CALL
Arena Group
AREN
$54.8M
$77.4K ﹤0.01%
+16,900
New +$67.2K
SLRN
11202
PUT
DELISTED
ACELYRIN
SLRN
$77.3K ﹤0.01%
+3,700
New +$75.7K
IUSB icon
11203
CALL
iShares Core Universal USD Bond ETF
IUSB
$43.2B
$77.3K ﹤0.01%
1,700
-22,500
-93% -$1.03M
PBH icon
11204
PUT
Prestige Consumer Healthcare
PBH
$2.43B
$77.3K ﹤0.01%
1,300
+1,200
+1,200% +$71.8K
IPSC icon
11205
Century Therapeutics
IPSC
$348M
$77.2K ﹤0.01%
24,445
-27,755
-53% -$89.5K
RIDE
11206
PUT
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$77.2K ﹤0.01%
36,224
-6,149
-15% -$32.2K
RCEL icon
11207
Avita Medical
RCEL
$243M
$77.1K ﹤0.01%
4,535
-104,204
-96% -$1.53M
HTO
11208
PUT
H2O America
HTO
$2.67B
$77.1K ﹤0.01%
+1,100
New +$83.1K
REK icon
11209
CALL
ProShares Short Real Estate
REK
$11.7M
$77K ﹤0.01%
3,900
-40,600
-91% -$828K
HDB icon
11210
PUT
HDFC Bank
HDB
$120B
$76.7K ﹤0.01%
2,200
-57,800
-96% -$1.95M
EXFY icon
11211
PUT
Expensify
EXFY
$210M
$76.6K ﹤0.01%
9,600
-3,100
-24% -$22.7K
PUK icon
11212
CALL
Prudential
PUK
$34.7B
$76.5K ﹤0.01%
2,700
-7,700
-74% -$220K
ACHV icon
11213
Achieve Life Sciences
ACHV
$779M
$76.2K ﹤0.01%
14,689
+12,196
+489% +$85.5K
SPTM icon
11214
PUT
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
$76.2K ﹤0.01%
1,400
+1,300
+1,300% +$67.1K
PVBC
11215
CALL
DELISTED
Provident Bancorp
PVBC
$76.2K ﹤0.01%
9,200
+6,400
+229% +$48.3K
CINT icon
11216
CI&T Inc
CINT
$469M
$76.1K ﹤0.01%
+12,139
New +$58.6K
CKPT
11217
CALL
DELISTED
Checkpoint Therapeutics
CKPT
$76.1K ﹤0.01%
30,800
-13,160
-30% -$35.9K
PWP icon
11218
Perella Weinberg Partners
PWP
$1.29B
$76.1K ﹤0.01%
9,130
-62,727
-87% -$518K
EPP icon
11219
CALL
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
$76K ﹤0.01%
1,800
-1,900
-51% -$82.3K
TBHC
11220
DELISTED
The Brand House Collective
TBHC
$76K ﹤0.01%
+27,237
New +$78.9K
PHAT icon
11221
PUT
Phathom Pharmaceuticals
PHAT
$775M
$75.9K ﹤0.01%
5,300
+3,400
+179% +$39.2K
MPX
11222
PUT
DELISTED
Marine Products Corp
MPX
$75.9K ﹤0.01%
4,500
-7,600
-63% -$112K
TDCX
11223
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$75.7K ﹤0.01%
+9,576
New +$78.9K
GANX icon
11224
CALL
Gain Therapeutics
GANX
$90.4M
$75.7K ﹤0.01%
16,900
+4,100
+32% +$20K
CORT icon
11225
PUT
Corcept Therapeutics
CORT
$12.4B
$75.7K ﹤0.01%
3,400
-18,600
-85% -$428K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.